Artwork

内容由Keck Graduate Institute (KGI) and Keck Graduate Institute提供。所有播客内容(包括剧集、图形和播客描述)均由 Keck Graduate Institute (KGI) and Keck Graduate Institute 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

#132 - Ankit Lodha, MBS '13

47:49
 
分享
 

已归档的系列专辑 ("不活跃的收取点" status)

When? This feed was archived on July 28, 2023 09:02 (8M ago). Last successful fetch was on June 27, 2023 13:06 (9M ago)

Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间,但仍然无法截取有效的播客收取点

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 295519920 series 2093707
内容由Keck Graduate Institute (KGI) and Keck Graduate Institute提供。所有播客内容(包括剧集、图形和播客描述)均由 Keck Graduate Institute (KGI) and Keck Graduate Institute 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this summer speaker series, we hear from Ankit Lodha, MBS ’13, Director Data Science Portfolio Management, Janssen Research & Development.

Lodha executes various AI/ML models in supporting the execution of clinical trial portfolios. He worked on the COVID-19 vaccine program to build a data-driven COVID-19 Vaccine Development approach for Janssen and operationalizes across multiple high priority areas, for example, creating best-in-class R&D data science platforms and datasets by selecting the highest priority questions to pursue and systematically deploying Data Science capabilities, while being a key catalyst in forming strategic external partnerships to accelerate ongoing efforts.

Lodha has more than 10 years of global healthcare experience in pharmaceutical, biotechnology, and business. Prior to joining Janssen, he was a Team Lead at Takeda, where he led and executed multiple strategic initiatives across research, CRO management, clinical development, mergers and acquisitions, and operations. Preceding this role, he worked at Amgen in clinical systems & analytics organization within R&D; areas of focus included portfolio governance and decision making, R&D operating model optimization (including both clinical development and operations), external innovation, and digital health.

Lodha received a Bachelor’s in Biotechnology Engineering from Dr. D.Y. Patil University, a Master of Business and Science from Keck Graduate Institute, and an MBA from the University of Redlands – School of Business. He is the recipient of EB-1A status – i.e., Alien of Extraordinary Ability (a.k.a. “Einstein visa”) – in the field of Clinical Trial Analytics from the US government (USCIS). This honor is awarded to less than one percent of professionals globally who have risen to the very top of their endeavor and brought major significance to their field at the national and international levels.

  continue reading

100集单集

Artwork
icon分享
 

已归档的系列专辑 ("不活跃的收取点" status)

When? This feed was archived on July 28, 2023 09:02 (8M ago). Last successful fetch was on June 27, 2023 13:06 (9M ago)

Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间,但仍然无法截取有效的播客收取点

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 295519920 series 2093707
内容由Keck Graduate Institute (KGI) and Keck Graduate Institute提供。所有播客内容(包括剧集、图形和播客描述)均由 Keck Graduate Institute (KGI) and Keck Graduate Institute 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this summer speaker series, we hear from Ankit Lodha, MBS ’13, Director Data Science Portfolio Management, Janssen Research & Development.

Lodha executes various AI/ML models in supporting the execution of clinical trial portfolios. He worked on the COVID-19 vaccine program to build a data-driven COVID-19 Vaccine Development approach for Janssen and operationalizes across multiple high priority areas, for example, creating best-in-class R&D data science platforms and datasets by selecting the highest priority questions to pursue and systematically deploying Data Science capabilities, while being a key catalyst in forming strategic external partnerships to accelerate ongoing efforts.

Lodha has more than 10 years of global healthcare experience in pharmaceutical, biotechnology, and business. Prior to joining Janssen, he was a Team Lead at Takeda, where he led and executed multiple strategic initiatives across research, CRO management, clinical development, mergers and acquisitions, and operations. Preceding this role, he worked at Amgen in clinical systems & analytics organization within R&D; areas of focus included portfolio governance and decision making, R&D operating model optimization (including both clinical development and operations), external innovation, and digital health.

Lodha received a Bachelor’s in Biotechnology Engineering from Dr. D.Y. Patil University, a Master of Business and Science from Keck Graduate Institute, and an MBA from the University of Redlands – School of Business. He is the recipient of EB-1A status – i.e., Alien of Extraordinary Ability (a.k.a. “Einstein visa”) – in the field of Clinical Trial Analytics from the US government (USCIS). This honor is awarded to less than one percent of professionals globally who have risen to the very top of their endeavor and brought major significance to their field at the national and international levels.

  continue reading

100集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南